CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net income	$ 31,933	$ 30,299
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	144,724	132,931
Share-based compensation expense	5,303	5,491
Income from unconsolidated joint venture	(801)	(1,034)
Distributions from unconsolidated joint venture	1,670	1,335
(Gain) loss on sale of real estate, net	(1,991)	37
Changes in operating assets and liabilities:
Receivables and other assets, net	2,504	457
Accounts payable and accrued liabilities	(6,337)	(23,262)
Security deposits, prepaid rent and other liabilities	5,178	2,483
Net cash provided by operating activities	182,183	148,737
Cash flows from investing activities:
Investments in real estate	(41,338)	(93,855)
Development of real estate	(30,367)	(4,627)
Proceeds from the sale of real estate	6,420	1,193
Capital expenditures	(43,917)	(37,763)
Collection of real estate notes receivable	514	365
Advances on real estate notes receivable	(6,000)	0
Net cash used in investing activities	(114,688)	(134,687)
Cash flows from financing activities:
Borrowings on unsecured revolving credit facility	1,314,000	135,000
Payments on unsecured revolving credit facility	(1,150,000)	(15,000)
Payments on secured mortgage loans	(96,206)	(96,173)
Proceeds from issuance of common stock	50,020	0
Issuance of OP Units	1,378	0
Repurchase and cancellation of common stock	(4,798)	(12,095)
Dividends paid	(137,050)	(127,387)
Distributions paid to noncontrolling interest of limited partners	(2,455)	(2,781)
Net cash used in financing activities	(25,111)	(118,436)
Net change in cash, cash equivalents and restricted cash	42,384	(104,386)
Cash, cash equivalents and restricted cash - beginning of period	37,616	133,530
Cash, cash equivalents and restricted cash - end of period	80,000	29,144
Healthcare Trust of America Holdings, LP (HTALP)
Cash flows from operating activities:
Net income	31,933	30,299
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	144,724	132,931
Share-based compensation expense	5,303	5,491
Income from unconsolidated joint venture	(801)	(1,034)
Distributions from unconsolidated joint venture	1,670	1,335
(Gain) loss on sale of real estate, net	(1,991)	37
Changes in operating assets and liabilities:
Receivables and other assets, net	2,504	457
Accounts payable and accrued liabilities	(6,337)	(23,262)
Security deposits, prepaid rent and other liabilities	5,178	2,483
Net cash provided by operating activities	182,183	148,737
Cash flows from investing activities:
Investments in real estate	(41,338)	(93,855)
Development of real estate	(30,367)	(4,627)
Proceeds from the sale of real estate	6,420	1,193
Capital expenditures	(43,917)	(37,763)
Collection of real estate notes receivable	514	365
Advances on real estate notes receivable	(6,000)	0
Net cash used in investing activities	(114,688)	(134,687)
Cash flows from financing activities:
Borrowings on unsecured revolving credit facility	1,314,000	135,000
Payments on unsecured revolving credit facility	(1,150,000)	(15,000)
Payments on secured mortgage loans	(96,206)	(96,173)
Issuance of OP Units	1,378	0
Proceeds from issuance of general partner units	50,020	0
Repurchase and cancellation of general partner units	(4,798)	(12,095)
Distributions paid to general partner	(137,050)	(127,387)
Distributions paid to limited partners and redeemable noncontrolling interests	(2,455)	(2,781)
Net cash used in financing activities	(25,111)	(118,436)
Net change in cash, cash equivalents and restricted cash	42,384	(104,386)
Cash, cash equivalents and restricted cash - beginning of period	37,616	133,530
Cash, cash equivalents and restricted cash - end of period	$ 80,000	$ 29,144